Forbes November 10, 2023
Robert Hart

Topline

The Food and Drug Administration on Thursday approved the world’s first vaccine for chikungunya, a mosquito-borne virus with similar symptoms to dengue and Zika that experts warn is a major global health threat that the climate crisis is propelling to new parts of the world, including the United States.

Key Facts

News Peg

The FDA said it had approved the first chikungunya vaccine for use in adults ages 18 and older who are at high risk of catching the virus. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said the approval “addresses an unmet medical need and is an important advancement in the prevention of a potentially debilitating disease with limited treatment options.” The shot,...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, FDA, Govt Agencies, Healthcare System, Pharma, Pharma / Biotech, Public Health / COVID
FDA issues flu vaccine recommendations: 5 respiratory updates
5 Digital Health Areas To Be Impacted By The FDA Layoffs
FDA Approves First Biosimilar to Omalizumab
Trump's Nominees to Run FDA, NIH Get Greenlighted by Senate Committee
FDA Debuts a New Communications and Compliance Tool for Device Data Integrity Concerns

Share This Article